Profile

Bryan H. King, MD

Bryan H. King, MD

Psychiatry and Behavioral Health, Autism Center

On staff since September 2005

Children's Title: Director, Psychiatry and Behavioral Medicine; Program Director, Seattle Children's Autism Center

Research Center: Center for Child Health, Behavior and Development

Recommendations

  • Crystal Littleton NH 09.16.11

    I miss Dr. King so much. He was Jacy's doctor from the time he was 5 til he was 10 and there has never been anyone else like him. I wish he had been here a couple years ago so I could have brought my son to him for the most difficult situations I have ever had and I thought it was bad when he was younger I had no clue. Miss you Bryan lots. Crystal and Jacy McAlpin

  • Amy Quincy, CA 07.30.11

    Five years ago, our then 6 year old son experienced a horrifying and acute developmental regression. While other specialists (about 40 in total) were mystified by the disorder and offered little in answers, hope or treatment, Dr. King was open-minded and willing to examine our son's situation holistically. After detoxing him from previously prescribed meds that were not helping, he tried a med that he had been researching and led a team of specialists to address all of our son's needs, including education, speech, behavioral, and ocupational therapy. I'm happy to report that five years and countless hours of work later, our son is on a remarkable path to recovery and a fulfilling life. Before we came to Dr. King we were almost out of options and hope for our son, Dr. King's compassion and innovation to try something different literally saved our son.

Overview

Board Certification(s)

Child and Adolescent Psychiatry
Psychiatry

Medical/Professional School

Medical College of Wisconsin, Milwaukee
George Washington University, Washington

Residency

Psychiatry, UCLA Neuropsychiatric Hospital, Los Angeles

Fellowship

Child and Adolescent Psychiatry, UCLA Neuropsychiatric Hospital, Los Angeles

Clinical Interests

Autism, Developmental Disabilities, Child and Adolescent Psychiatry

Research Focus Area

Behavioral / Mental Health

Awards and Honors

Award Name Award Description Awarded By Award Date
SEATTLE'S TOP DOCTOR - 2014 Seattle Metropolitan Magazine 2014
SEATTLE MAGAZINE TOP DOCTOR - 2014 Seattle Magazine 2014
Seattle's Top Doc Seattle Met Magazine 2013
Seattle Magazine Top Doctor - 2013 Seattle Magazine 2013
U.S. News Top Doctor U.S. News and World Report 2012
"Guide to America's Top Pediatricians" Consumer's Research Council of America 2009

Publications

  • Swedo SE, Baird G, Cook EH Jr, Happé FG, Harris JC, Kaufmann WE, King BH, Lord CE, Piven J, Rogers SJ, Spence SJ, Wetherby A, Wright HH
    Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry , 2012 Apr, : 51(4)347-9
  • Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A
    Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
    Journal of autism and developmental disorders , 2012 Mar. : 42(3)432-40
  • Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, Martin LA, Millen KJ, Mittleman G, Mosconi MW, Persico AM, Sweeney JA, Webb SJ, Welsh JP
    Consensus Paper: Pathological Role of the Cerebellum in Autism.
    Cerebellum (London, England) , 2012 Feb. 28
  • Totoritis R, Duraiswami C, Taylor AN, Kerrigan JJ, Campobasso N, Smith KJ, Ward P, King BW, Murrayz-Thompson M, Jones AD, Van Aller GS, Aubart KM, Zalacain M, Thrall SH, Meek TD, Schwartz B
    Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
    Biochemistry , 2011 Aug. 9 : 50(31)6642-54
  • King BH, Lord C
    Is schizophrenia on the autism spectrum?
    Brain research , 2011 Mar. 22 : 138034-41
  • Yen CF, King BH, Tang TC
    The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents.
    Psychiatry research , 2010 Aug. 30 : 179(1)69-74
  • Yen CF, King BH, Tang TC
    The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents.
    Psychiatry research , 2010 Aug. 30 : 69-74
  • Yen CF, King BH, Chang YP
    Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents.
    Journal of sleep research , 2010 Mar. : 19(1 Pt 1)12-8
  • Yen CF, King BH, Chang YP
    Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents.
    Journal of sleep research , 2010 Mar. : 12-8
  • King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L, STAART Psychopharmacology Network
    Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    Archives of general psychiatry , 2009 June : 66(6)583-90
  • King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L
    Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    Archives of general psychiatry , 2009 June : 583-90
  • Brkanac Z, Raskind WH, King BH
    Pharmacology and genetics of autism: implications for diagnosis and treatment.
    Personalized medicine , 2008 Nov. : 5(6)599-607
  • Brkanac Z, Raskind WH, King BH
    Pharmacology and genetics of autism: implications for diagnosis and treatment.
    Personalized medicine , 2008 Nov. : 599-607
  • Toth K, King BH
    Asperger's syndrome: diagnosis and treatment.
    The American journal of psychiatry , 2008 Aug. : 165(8)958-63
  • Toth K, King BH
    Asperger's syndrome: diagnosis and treatment.
    The American journal of psychiatry , 2008 Aug. : 958-63
  • Pollard KS, Salama SR, King B, Kern AD, Dreszer T, Katzman S, Siepel A, Pedersen JS, Bejerano G, Baertsch R, Rosenbloom KR, Kent J, Haussler D
    Forces shaping the fastest evolving regions in the human genome.
    PLoS genetics , 2006 Oct. 13 : 2(10)e168
  • Pollard KS, Salama SR, Lambert N, Lambot MA, Coppens S, Pedersen JS, Katzman S, King B, Onodera C, Siepel A, Kern AD, Dehay C, Igel H, Ares M Jr, Vanderhaeghen P, Haussler D
    An RNA gene expressed during cortical development evolved rapidly in humans.
    Nature , 2006 Sept. 14 : 443(7108)167-72
  • King BH, Bostic JQ
    An update on pharmacologic treatments for autism spectrum disorders.
    Child and adolescent psychiatric clinics of North America , 2006 Jan. : 15(1)161-75
  • King BH, Bostic JQ
    An update on pharmacologic treatments for autism spectrum disorders.
    Child and adolescent psychiatric clinics of North America , 2006 Jan. : 161-75
  • Bostic JQ, King BH
    Autism spectrum disorders: emerging pharmacotherapy.
    Expert opinion on emerging drugs , 2005 Aug. : 10(3)521-36
  • Bostic JQ, King BH
    Autism spectrum disorders: emerging pharmacotherapy.
    Expert opinion on emerging drugs , 2005 Aug. : 521-36
  • Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M
    Outcome measures for clinical drug trials in autism.
    CNS spectrums , 2004 Jan. : 9(1)36-47
  • Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R
    Impact of recent findings on study design of future autism clinical trials.
    CNS spectrums , 2004 Jan. : 9(1)49-56
  • Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M
    Outcome measures for clinical drug trials in autism.
    CNS spectrums , 2004 Jan. : 36-47
  • Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R
    Impact of recent findings on study design of future autism clinical trials.
    CNS spectrums , 2004 Jan. : 49-56
  • Foster B, King BH
    Asperger syndrome: to be or not to be?
    Current opinion in pediatrics , 2003 Oct. : 15(5)491-4
  • Foster B, King BH
    Asperger syndrome: to be or not to be?
    Current opinion in pediatrics , 2003 Oct. : 491-4
  • Lewis MA, Lewis CE, Leake B, King BH, Lindemann R
    The quality of health care for adults with developmental disabilities.
    Public health reports (Washington, D.C. : 1974) , 2002 Mar. : 117(2)174-84
  • Lewis MA, Lewis CE, Leake B, King BH, Lindemann R
    The quality of health care for adults with developmental disabilities.
    Public health reports (Washington, D.C. : 1974) , 2002 Mar. : 174-84

Presentations

Presentations Title Event Location Date
Master Clinician, Bryan H. King, MD 56th Annual meeting of the American Academy of Child and Adolescent Psychiatry Honolulu, HI Nov. 1, 2009
A comprehensive approach to psychopharmacology in intellectual disabilities 56th Annual meeting of the American Academy of Child and Adolescent Psychiatry Honolulu, HI Nov. 1, 2009
Autism Yesterday, Today, and Tomorrow First Annual TESSERA Conference Bellevue, WA Nov. 1, 2009
Appropriate medication use in autism The HELP Group Summit 2009 Los Angeles, CA Nov. 1, 2009
Autism Past, Present, and Future The HELP Group Summit 2009 Los Angeles, CA Nov. 1, 2009
Pharmacotherapy in Autism: Time for an Update Grand Rounds Presentation, University of Massachusetts Worchester, MA June 1, 2009
Psychopharmacologic Treatment in Intellectual Disability. Keynote Presentation Building Solutions through Community Collaboration: Enhancing Services for Individuals who are Dually Served. Conference sponsored by California State Department of Developmental Services and the San Diego Regional Center Ontario, CA March 1, 2009

Research Funding

Grant Title Grantor Amount Award Date
EXTENDED MANAGEMENT AND MEASUREMENT OF AUTISM UNKNOWN $104,904.00 Nov. 1, 2008
AUTISM INTERVENTION RESEARCH NETWORK—PHYSICAL (AIR-P) HRSA $242,466.00 Oct. 1, 2008
AUTISM INTERVENTION RESEARCH NETWORK—BEHAVIOR (AIR-B) HRSA $700,768.00 Oct. 1, 2008
AUTISM TREATMENT NETWORK REGISTRY UNIVERSITY OF WASHINGTON, AUTISM SPEAKS $479,000.00 Jan. 1, 2008
A STUDY OF FLUOXETINE IN AUTISM AUTISM SPEAKS $132,092.00 July 1, 2007
UW AUTISM CENTER OF EXCELLENCE (P50 HD055782) NICHD $9,330,000.00 June 1, 2007